FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX

MDR report key: 3379033 · Received October 1, 2013

Report

Report Number
9612164-2013-00951
Event Type
Death
Date Received
October 1, 2013
Date of Event
January 1, 2013
Report Date
September 4, 2013
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). USEFULNESS OF INTRAVASCULAR ULTRASOUND TO PREDICT OUTCOMES AMERICAN JOURNAL OF CARDIOLOGY ALERT, 2013, VOL. 112, ISSUE 5 (WWW.AJCONLINE.ORG) 2013 0002-9149/13/$.

Description of Event or Problem · 1

A STUDY WAS CARRIED OUT TO SEE THE ¿USEFULNESS OF INTRAVASCULAR ULTRASOUND TO PREDICT OUTCOMES IN SHORT-LENGTH LESIONS TREATED WITH DRUG-ELUTING STENTS¿. A TOTAL OF 662 PATIENT WITH IVUS GUIDANCE AND 912 PATIENTS WITH ANGIOGRAPHY GUIDANCE WHO UNDERWENT DES IMPLANTATION WERE INVOLVED IN THE STUDY. PATIENT OUTCOMES INCLUDED DEATH, MI, STENT THROMBOSIS AND REVASCULARIZATIONS. THE STUDY CONCLUDED THAT THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCES FOUND BETWEEN THE 2 GROUPS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
493914 ENDEAVOR SPRINT RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 00062 YR Death